Warren Cresswell

President Americas since 2021

M.B.A. from the University of Pittsburgh and B.A. in Chemistry from California State University, Northridge. Warren has over 25 years of experience in the diagnostics industry. He was previously CEO at Prometheus Labs, CEO at Microbiome Diagnostic Partners, and Vice President at Dako, leading the Asia Pacific Business Unit.

Current assignments: Board member at Demeter Sciences.

Holdings: 100,000 TO9, 24 000 stock options 23/26:1 and 8 000 stock options 23/26:2.


Numbers of patients in studies




Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program